Singapore markets closed

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
0.9650-0.0050 (-0.52%)
At close: 04:56PM SGT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.98B
Enterprise value 1.63B
Trailing P/E 6.85
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.75
Price/book (mrq)0.83
Enterprise value/revenue 0.23
Enterprise value/EBITDA 1.44

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-3.96%
S&P500 52-week change 3-16.34%
52-week high 31.2100
52-week low 30.9500
50-day moving average 31.0265
200-day moving average 31.0686

Share statistics

Avg vol (3-month) 371.03k
Avg vol (10-day) 394.36k
Shares outstanding 5200M
Implied shares outstanding 6N/A
Float 8426.55M
% held by insiders 10.00%
% held by institutions 10.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.07
Forward annual dividend yield 47.47%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 351.55%
5-year average dividend yield 44.10
Payout ratio 449.54%
Dividend date 3N/A
Ex-dividend date 424 May 2022
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022


Profit margin 11.01%
Operating margin (ttm)8.57%

Management effectiveness

Return on assets (ttm)4.13%
Return on equity (ttm)12.40%

Income statement

Revenue (ttm)7.04B
Revenue per share (ttm)9.17
Quarterly revenue growth (yoy)4.00%
Gross profit (ttm)2.75B
EBITDA 711.88M
Net income avi to common (ttm)775.38M
Diluted EPS (ttm)0.1400
Quarterly earnings growth (yoy)7.80%

Balance sheet

Total cash (mrq)2.6B
Total cash per share (mrq)3.36
Total debt (mrq)61.92M
Total debt/equity (mrq)0.94
Current ratio (mrq)2.61
Book value per share (mrq)8.34

Cash flow statement

Operating cash flow (ttm)571.57M
Levered free cash flow (ttm)268.74M